New blood test close to ‘cracking the code’ on pancreatic cancer early detection
An investigational exosome-based liquid biopsy showed better than 90% accuracy for detecting early-stage pancreatic cancer among U.S.-based participants in a prospective multicenter study. When combined with a signature that identified the protein CA 19-9, a known tumor biomarker for pancreatic cancer, the novel liquid biopsy accurately detected 97% of stage I or stage II pancreatic ductal